marketcaparena
Search

    EW

    Edwards Lifesciences Corp

    Company overview

    Market capitalization
    $50.05B
    Employees
    16,000
    Latest publication
    2026-09-29
    About Edwards Lifesciences Corp

    Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. It distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

    Company website

    Financial statements

    Income YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Total Revenue3,389,600,000USD
    Cost Of Revenue755,000,000USD
    Gross Profit2,634,600,000USD
    Research Development542,200,000USD
    Selling General Administrative1,083,400,000USD
    Other Operating Expenses-25,200,000USD
    Total Operating Expenses1,643,800,000USD
    Operating Income990,800,000USD
    Total Other Income Expense Net-12,000,000USD
    Interest Income63,500,000USD
    Litigation Settlement Expense43,400,000USD
    Income Before Tax978,800,000USD
    Income Tax Expense356,700,000USD
    Discontinued Operations0USD
    Net Income622,100,000USD
    Minority Interest-500,000USD
    Net Income Applicable To Common Shares622,600,000USD
    SourceDisclosureDeterministicFinal

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ3 20252025-09-30 · USDQ2 20242024-06-30 · USDQ1 20232023-03-31 · USDQ4 20222022-12-31 · USDQ3 20222022-09-30 · USDQ2 20222022-06-30 · USD
    Total Revenue1,741,000,000USD1,648,600,000USD1,553,100,000USD1,385,900,000USD1,459,600,000USD1,348,300,000USD1,319,000,000USD1,373,900,000USD
    Cost Of Revenue392,400,000USD359,300,000USD345,200,000USD297,800,000USD359,300,000USD295,600,000USD280,900,000USD285,700,000USD
    Gross Profit1,348,600,000USD1,289,300,000USD1,209,600,000USD1,088,100,000USD1,100,300,000USD1,052,700,000USD1,038,099,999USD1,088,200,000USD
    Research Development278,900,000USD263,300,000USD280,700,000USD272,600,000USD261,200,000USD232,200,000USD233,600,000USD250,800,000USD
    Selling General Administrative561,200,000USD522,200,000USD514,600,000USD450,800,000USD437,000,000USD411,000,000USD377,300,000USD388,100,000USD
    Other Operating Expenses-11,000,000USD———————
    Total Operating Expenses835,400,000USD774,600,000USD784,500,000USD723,400,000USD697,500,000USD643,200,000USD610,900,000USD659,800,000USD
    Operating Income513,200,000USD514,700,000USD425,100,000USD364,700,000USD402,800,000USD409,500,000USD427,200,000USD428,400,000USD
    Total Other Income Expense Net6,600,000USD-55,700,000USD-76,700,000USD21,900,000USD-4,200,000USD49,800,000USD-19,900,000USD36,300,000USD
    Interest Income30,000,000USD—38,600,000USD15,500,000USD8,600,000USD7,900,000USD6,900,000USD3,700,000USD
    Litigation Settlement Expense6,300,000USD———————
    Income Before Tax519,800,000USD459,000,000USD348,400,000USD386,600,000USD398,600,000USD459,300,000USD407,300,000USD464,700,000USD
    Income Tax Expense278,400,000USD78,300,000USD56,100,000USD20,200,000USD58,100,000USD60,900,000USD63,800,000USD58,300,000USD
    Discontinued Operations0USD———————
    Net Income241,400,000USD380,700,000USD291,100,000USD363,700,000USD340,500,000USD398,400,000USD343,500,000USD406,400,000USD
    Minority Interest-500,000USD0USD800,000USD1,300,000USD0USD———
    Net Income Applicable To Common Shares241,900,000USD—291,100,000USD—340,500,000USD398,400,000USD343,500,000USD406,400,000USD
    Unclassified Operating Expenses—-10,900,000USD-10,800,000USD————20,900,000USD
    Net Interest Income—33,500,000USD38,600,000USD15,500,000USD8,600,000USD7,900,000USD6,900,000USD900,000USD
    Tax Provision—78,300,000USD56,100,000USD20,200,000USD58,100,000USD60,900,000USD63,800,000USD58,300,000USD
    Net Income From Continuing Ops—380,700,000USD292,300,000USD366,400,000USD340,500,000USD398,400,000USD343,500,000USD406,400,000USD
    Ebit—459,000,000USD348,400,000USD386,600,000USD398,600,000USD459,300,000USD407,300,000USD465,800,000USD
    Ebitda—499,900,000USD387,600,000USD426,200,000USD440,600,000USD501,300,000USD449,400,000USD506,700,000USD
    Depreciation And Amortization—40,900,000USD39,200,000USD39,600,000USD42,000,000USD42,000,000USD42,100,000USD40,900,000USD
    Reconciled Depreciation—40,900,000USD39,200,000USD39,600,000USD35,200,000USD35,400,000USD35,400,000USD34,100,000USD
    Interest Expense————10,200,000USD7,900,000USD6,900,000USD1,100,000USD
    Non Operating Income Net Other————1,600,000USD39,100,000USD-2,000,000USD4,300,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USDFY 20162016-12-31 · USDFY 20152015-12-31 · USD
    Total Revenue6,004,800,000USD5,382,400,000USD5,232,500,000USD4,386,300,000USD4,348,000,000USD3,722,800,000USD2,963,700,000USD2,493,700,000USD
    Cost Of Revenue1,379,800,000USD1,167,200,000USD1,225,900,000USD1,099,000,000USD1,155,300,000USD922,100,000USD805,800,000USD684,300,000USD
    Gross Profit4,625,000,000USD4,215,200,000USD4,006,600,000USD3,287,300,000USD3,192,700,000USD2,800,700,000USD2,157,900,000USD1,809,400,000USD
    Research Development1,071,800,000USD945,200,000USD903,100,000USD760,700,000USD752,700,000USD622,200,000USD442,200,000USD383,100,000USD
    Selling General Administrative1,755,600,000USD1,566,500,000USD1,494,000,000USD1,228,400,000USD1,242,200,000USD1,088,500,000USD904,700,000USD850,700,000USD
    Selling And Marketing Expenses1,200,000USD1,100,000USD300,000USD—————
    Unclassified Operating Expenses67,800,000USD———————
    Total Operating Expenses2,896,400,000USD2,512,800,000USD2,396,200,000USD1,991,300,000USD1,994,800,000USD1,708,400,000USD1,342,400,000USD1,233,500,000USD
    Operating Income1,534,100,000USD1,702,400,000USD1,610,400,000USD1,296,000,000USD1,197,900,000USD1,092,300,000USD815,500,000USD575,900,000USD
    Interest Income67,200,000USD16,300,000USD1,000,000USD7,600,000USD32,200,000USD32,000,000USD10,800,000USD—
    Interest Expense17,600,000USD26,200,000USD24,800,000USD22,200,000USD27,300,000USD33,400,000USD18,000,000USD18,400,000USD
    Net Interest Income40,700,000USD16,300,000USD-1,000,000USD7,600,000USD11,500,000USD2,100,000USD-8,400,000USD—
    Income Before Tax1,598,100,000USD1,767,400,000USD1,702,000,000USD916,700,000USD1,166,500,000USD761,400,000USD737,900,000USD622,400,000USD
    Income Tax Expense198,700,000USD245,500,000USD198,900,000USD93,300,000USD119,600,000USD39,200,000USD168,400,000USD127,500,000USD
    Tax Provision207,600,000USD245,500,000USD198,900,000USD93,300,000USD119,600,000USD39,200,000USD168,400,000USD127,500,000USD
    Net Income1,402,400,000USD1,521,900,000USD1,503,100,000USD823,400,000USD1,046,900,000USD722,200,000USD569,500,000USD494,900,000USD
    Net Income From Continuing Ops1,428,100,000USD1,521,900,000USD1,503,100,000USD823,400,000USD1,046,900,000USD722,200,000USD569,500,000USD494,900,000USD
    Ebit1,534,100,000USD1,793,600,000USD1,726,800,000USD938,900,000USD1,193,800,000USD794,800,000USD755,900,000USD640,800,000USD
    Ebitda1,534,100,000USD1,960,400,000USD1,890,100,000USD1,074,300,000USD1,308,400,000USD872,200,000USD827,100,000USD706,600,000USD
    Depreciation And Amortization144,900,000USD166,800,000USD163,300,000USD135,400,000USD114,600,000USD77,400,000USD71,200,000USD65,800,000USD
    Reconciled Depreciation143,600,000USD139,600,000USD134,800,000USD107,200,000USD89,300,000USD77,400,000USD——
    Total Other Income Expense Net64,000,000USD65,000,000USD91,600,000USD-379,300,000USD-31,400,000USD-330,900,000USD-77,600,000USD46,500,000USD
    Minority Interest3,000,000USD0USD0USD—————
    Net Income Applicable To Common Shares1,402,400,000USD1,521,900,000USD1,503,100,000USD823,400,000USD1,046,900,000USD722,200,000USD569,500,000USD494,900,000USD
    Non Operating Income Net Other—38,100,000USD30,100,000USD34,900,000USD40,400,000USD36,000,000USD5,900,000USD3,900,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets13,867,100,000USD13,321,200,000USD13,697,200,000USD13,272,200,000USD13,488,700,000USD13,022,300,000USD13,055,300,000USD12,971,200,000USD
    Cash And Equivalents2,906,500,000USD—2,938,000,000USD2,685,600,000USD3,272,800,000USD3,140,600,000USD3,045,200,000USD3,676,400,000USD
    Cash And Short Term Investments4,252,700,000USD3,672,500,000USD4,226,800,000USD3,842,000,000USD4,062,200,000USD3,898,500,000USD3,975,900,000USD4,446,100,000USD
    Short Term Investments1,346,200,000USD1,226,000,000USD1,288,300,000USD1,156,400,000USD789,400,000USD757,900,000USD930,700,000USD769,700,000USD
    Long Term Investments244,100,000USD285,600,000USD278,600,000USD274,700,000USD298,500,000USD277,900,000USD307,900,000USD319,600,000USD
    Total Current Assets6,818,900,000USD6,228,700,000USD6,738,900,000USD6,358,900,000USD6,577,200,000USD6,212,700,000USD6,285,400,000USD6,727,700,000USD
    Other Current Assets360,300,000USD464,200,000USD473,800,000USD483,200,000USD470,700,000USD448,400,000USD495,400,000USD365,900,000USD
    Other Non Current Assets616,400,000USD———————
    Total Liabilities3,142,200,000USD———————
    Total Current Liabilities1,507,900,000USD1,409,000,000USD1,813,700,000USD1,588,000,000USD1,404,700,000USD1,394,800,000USD1,505,200,000USD1,944,100,000USD
    Other Non Current Liabilities381,800,000USD———————
    Total Stockholder Equity10,618,000,000USD10,327,500,000USD10,337,600,000USD10,205,000,000USD10,545,300,000USD10,128,700,000USD9,998,400,000USD9,545,600,000USD
    Total Equity Including Noncontrolling Interest10,724,900,000USD———————
    Long Term Debt598,700,000USD598,500,000USD598,300,000USD598,200,000USD598,000,000USD597,800,000USD597,700,000USD597,500,000USD
    Net Receivables770,400,000USD973,000,000USD912,100,000USD892,800,000USD902,600,000USD751,900,000USD727,400,000USD811,500,000USD
    Inventory1,131,200,000USD1,119,000,000USD1,126,200,000USD1,140,900,000USD1,141,700,000USD1,113,900,000USD1,086,700,000USD1,104,200,000USD
    Property Plant Equipment Net1,942,100,000USD1,922,400,000USD1,914,600,000USD1,839,800,000USD1,825,600,000USD1,795,200,000USD1,784,200,000USD1,780,100,000USD
    Goodwill1,951,200,000USD———————
    Intangible Assets1,382,600,000USD1,227,900,000USD1,128,200,000USD1,130,800,000USD1,172,800,000USD1,174,900,000USD1,176,600,000USD956,100,000USD
    Accounts Payable210,500,000USD181,100,000USD227,500,000USD165,000,000USD162,100,000USD172,400,000USD197,400,000USD172,800,000USD
    Common Stock661,700,000USD660,000,000USD658,700,000USD658,200,000USD657,600,000USD655,900,000USD654,800,000USD654,300,000USD
    Retained Earnings14,863,100,000USD14,621,200,000USD14,240,500,000USD14,149,300,000USD13,858,200,000USD13,525,000,000USD13,167,000,000USD12,781,400,000USD
    Accumulated Other Comprehensive Income-214,600,000USD-221,299,999USD-238,300,000USD-250,400,000USD-264,100,000USD-254,500,000USD-244,500,000USD-252,500,000USD
    Total Liab—2,993,700,000USD3,359,600,000USD3,067,200,000USD2,882,200,000USD2,830,700,000USD2,992,400,000USD3,359,800,000USD
    Other Current Liab—1,180,799,999USD1,534,500,000USD1,363,000,000USD1,179,900,000USD775,800,000USD856,000,000USD882,300,000USD
    Capital Stock—660,000,000USD658,700,000USD658,200,000USD657,600,000USD655,900,000USD654,800,000USD654,300,000USD
    Good Will—1,819,600,000USD1,768,600,000USD1,768,500,000USD1,776,700,000USD1,778,700,000USD1,776,700,000USD1,605,300,000USD
    Cash—2,446,500,000USD2,938,500,000USD2,685,600,000USD3,272,800,000USD3,140,600,000USD3,045,200,000USD3,676,400,000USD
    Current Deferred Revenue—22,800,000USD27,200,000USD33,200,000USD36,800,000USD46,200,000USD53,700,000USD66,000,000USD
    Net Debt—-1,743,600,000USD-2,233,100,000USD-1,985,300,000USD-2,570,200,000USD-2,441,200,000USD-2,345,200,000USD-2,969,700,000USD
    Short Term Debt—24,300,000USD24,500,000USD26,800,000USD25,900,000USD23,700,000USD23,400,000USD24,200,000USD
    Short Long Term Debt Total—702,900,000USD705,400,000USD700,300,000USD702,600,000USD699,400,000USD700,000,000USD706,700,000USD
    Property Plant Equipment Gross—1,922,400,000USD2,764,400,000USD1,839,800,000USD1,825,600,000USD1,795,200,000USD2,578,700,000USD1,780,100,000USD
    Common Stock Shares Outstanding—580,700,000shares581,800,000shares585,700,000shares587,900,000shares587,800,000shares590,500,000shares598,100,000shares
    Non Current Assets Total—7,092,500,000USD6,958,300,000USD6,913,300,000USD6,911,500,000USD6,809,600,000USD6,769,900,000USD6,243,500,000USD
    Non Current Liabilities Total—1,584,699,999USD1,545,900,000USD1,479,200,000USD1,477,500,000USD1,435,900,000USD1,487,200,000USD1,415,700,000USD
    Non Current Liabilities Other—906,100,000USD865,000,000USD805,500,000USD800,800,000USD760,200,000USD756,600,000USD668,200,000USD
    Non Currrent Assets Other—186,400,000USD234,900,000USD799,600,000USD755,800,000USD755,100,000USD732,400,000USD694,000,000USD
    Net Working Capital—4,819,700,000USD4,925,200,000USD4,770,900,000USD5,172,500,000USD4,817,900,000USD4,780,200,000USD4,783,600,000USD
    Unclassified Non Current Assets—1,650,600,000USD-234,900,000USD-799,600,000USD-755,800,000USD-755,100,000USD-732,400,000USD-694,000,000USD
    Unclassified Non Current Liabilities—80,099,999USD82,600,000USD75,500,000USD78,700,000USD77,900,000USD132,900,000USD150,000,000USD
    Unclassified Equity—-5,392,400,001USD-4,982,000,000USD-5,010,300,000USD-4,364,000,000USD-4,453,600,000USD-4,233,700,000USD-4,291,900,000USD
    Other Assets——1,868,300,000USD1,899,500,000USD1,837,900,000USD1,782,900,000USD1,724,500,000USD1,582,400,000USD
    Unclassified Current Liabilities—————376,700,000USD374,700,000USD798,800,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets13,697,200,000USD13,055,300,000USD9,363,200,000USD8,292,500,000USD8,502,600,000USD7,237,100,000USD6,488,100,000USD5,323,700,000USD
    Intangible Assets1,128,200,000USD1,176,600,000USD399,400,000USD285,200,000USD323,600,000USD331,400,000USD336,500,000USD343,200,000USD
    Other Current Assets473,800,000USD495,400,000USD671,300,000USD305,900,000USD322,300,000USD283,300,000USD227,100,000USD186,100,000USD
    Total Liab3,359,600,000USD2,992,400,000USD2,643,800,000USD2,485,800,000USD2,666,700,000USD2,662,800,000USD2,339,800,000USD2,183,300,000USD
    Total Stockholder Equity10,337,600,000USD9,998,400,000USD6,650,000,000USD5,806,700,000USD5,835,900,000USD4,574,300,000USD4,148,300,000USD3,140,400,000USD
    Other Current Liab1,534,500,000USD856,000,000USD879,400,000USD698,800,000USD702,800,000USD601,900,000USD592,200,000USD671,800,000USD
    Common Stock658,700,000USD654,800,000USD650,500,000USD646,300,000USD642,000,000USD636,400,000USD218,100,000USD215,200,000USD
    Capital Stock658,700,000USD654,800,000USD650,500,000USD646,300,000USD642,000,000USD636,400,000USD218,100,000USD215,200,000USD
    Retained Earnings14,240,500,000USD13,167,000,000USD8,992,400,000USD7,590,000,000USD6,068,100,000USD4,565,000,000USD3,741,600,000USD2,694,700,000USD
    Good Will1,768,600,000USD1,776,700,000USD1,145,100,000USD1,164,300,000USD1,167,900,000USD1,173,200,000USD1,167,700,000USD1,112,200,000USD
    Other Assets1,379,800,000USD1,724,500,000USD1,218,300,000USD783,100,000USD357,500,000USD1,247,000,000USD274,000,000USD207,600,000USD
    Cash2,938,500,000USD3,045,200,000USD1,132,300,000USD769,000,000USD862,800,000USD1,183,200,000USD1,179,100,000USD714,100,000USD
    Cash And Equivalents2,938,000,000USD3,045,200,000USD1,144,000,000USD769,000,000USD862,800,000USD1,183,200,000USD1,179,100,000USD714,100,000USD
    Cash And Short Term Investments4,226,800,000USD3,975,900,000USD1,632,800,000USD1,215,300,000USD1,466,800,000USD1,402,600,000USD1,516,900,000USD956,500,000USD
    Total Current Assets6,738,900,000USD6,285,400,000USD4,035,700,000USD3,095,800,000USD3,180,700,000USD3,091,000,000USD2,984,000,000USD2,286,900,000USD
    Total Current Liabilities1,813,700,000USD1,505,200,000USD1,195,400,000USD1,022,400,000USD1,032,300,000USD893,900,000USD902,400,000USD876,600,000USD
    Current Deferred Revenue27,200,000USD53,700,000USD953,900,000USD484,000,000USD798,400,000USD630,900,000USD690,100,000USD—
    Net Debt-2,233,100,000USD-2,345,200,000USD-447,200,000USD-77,700,000USD-172,500,000USD-488,300,000USD-500,300,000USD-120,300,000USD
    Short Term Debt24,500,000USD23,400,000USD22,900,000USD25,500,000USD25,500,000USD27,200,000USD25,500,000USD0USD
    Short Long Term Debt Total705,400,000USD700,000,000USD685,100,000USD691,300,000USD690,300,000USD694,900,000USD678,800,000USD593,800,000USD
    Long Term Debt598,300,000USD597,700,000USD597,000,000USD596,300,000USD595,700,000USD595,000,000USD594,400,000USD593,800,000USD
    Long Term Investments278,600,000USD307,900,000USD583,900,000USD1,239,000,000USD1,834,200,000USD801,600,000USD585,500,000USD506,300,000USD
    Short Term Investments1,288,300,000USD930,700,000USD500,500,000USD446,300,000USD604,000,000USD219,400,000USD337,800,000USD242,400,000USD
    Net Receivables912,100,000USD727,400,000USD828,100,000USD699,100,000USD664,900,000USD602,800,000USD599,100,000USD537,300,000USD
    Inventory1,126,200,000USD1,086,700,000USD903,500,000USD875,500,000USD726,700,000USD802,300,000USD640,900,000USD607,000,000USD
    Accounts Payable227,500,000USD197,400,000USD186,600,000USD201,900,000USD204,500,000USD196,500,000USD180,400,000USD134,000,000USD
    Property Plant Equipment Net1,914,600,000USD1,784,200,000USD1,675,400,000USD1,725,100,000USD1,638,700,000USD1,489,400,000USD1,140,400,000USD867,500,000USD
    Property Plant Equipment Gross2,764,400,000USD2,578,700,000USD2,700,800,000USD1,725,100,000USD1,638,700,000USD1,489,400,000USD1,140,400,000USD867,500,000USD
    Accumulated Other Comprehensive Income-238,300,000USD-244,500,000USD-242,800,000USD-254,900,000USD-157,700,000USD-161,100,000USD-156,000,000USD-138,500,000USD
    Common Stock Shares Outstanding585,800,000shares599,300,000shares609,400,000shares624,200,000shares631,200,000shares631,900,000shares636,599,987shares640,800,000shares
    Non Current Assets Total6,958,300,000USD6,769,900,000USD5,327,500,000USD5,196,700,000USD5,321,900,000USD4,146,100,000USD3,504,100,000USD3,036,800,000USD
    Non Current Liabilities Total1,545,900,000USD1,487,200,000USD1,448,400,000USD1,463,400,000USD1,634,400,000USD1,768,900,000USD1,437,400,000USD1,306,700,000USD
    Non Current Liabilities Other865,000,000USD756,600,000USD264,300,000USD511,200,000USD588,300,000USD885,900,000USD547,500,000USD453,500,000USD
    Non Currrent Assets Other234,900,000USD732,400,000USD774,300,000USD299,100,000USD110,800,000USD119,600,000USD101,800,000USD33,600,000USD
    Net Working Capital4,925,200,000USD4,780,200,000USD2,840,300,000USD2,073,400,000USD2,148,400,000USD2,197,100,000USD2,081,600,000USD1,410,300,000USD
    Unclassified Non Current Assets253,600,000USD-732,400,000USD-468,900,000USD-299,100,000USD-110,800,000USD-1,016,100,000USD-101,800,000USD-33,600,000USD
    Unclassified Non Current Liabilities82,600,000USD132,900,000USD587,100,000USD-441,700,000USD-519,200,000USD-813,200,000USD-488,600,000USD-453,500,000USD
    Unclassified Equity-4,982,000,000USD-4,233,700,000USD-3,400,600,000USD-2,821,000,000USD1,058,400,000USD801,700,000USD1,405,200,000USD1,169,200,000USD
    Unclassified Current Liabilities—374,700,000USD-847,400,000USD-387,800,000USD-698,900,000USD-562,600,000USD-585,800,000USD70,800,000USD
    Other Liab———797,600,000USD969,600,000USD1,101,200,000USD784,100,000USD712,900,000USD
    Net Tangible Assets———4,357,200,000USD4,344,400,000USD3,357,700,000USD2,939,600,000USD1,944,400,000USD
    Treasury Stock————-2,416,900,000USD-1,904,100,000USD-1,278,700,000USD-1,015,400,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Net Income622,100,000USD
    Depreciation83,600,000USD
    Stock Based Compensation87,600,000USD
    Deferred Income Tax190,700,000USD
    Other Non Cash Items81,300,000USD
    Change To Account Receivables-128,100,000USD
    Change To Inventory-25,100,000USD
    Change To Liabilities-223,400,000USD
    Change In Working Capital-369,600,000USD
    Operating Cash Flow695,700,000USD
    Capital Expenditures-131,800,000USD
    Net Investments-46,600,000USD
    Other Investing Activities-7,300,000USD
    Unclassified Investing Cash Flow-100,300,000USD
    Investing Cash Flow-286,000,000USD
    Common Stock Issuance122,700,000USD
    Net Common Stock Issuance-575,100,000USD
    Other Financing Activities900,000USD
    Financing Cash Flow-451,500,000USD
    Effect Of Forex Changes On Cash12,000,000USD
    Change In Cash-29,800,000USD
    End Cash Flow2,909,700,000USD
    SourceDisclosureDeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income380,700,000USD91,200,000USD290,300,000USD331,500,000USD358,000,000USD356,400,000USD3,069,400,000USD365,000,000USD
    Depreciation40,900,000USD42,700,000USD39,200,000USD38,100,000USD36,600,000USD36,600,000USD34,500,000USD39,600,000USD
    Stock Based Compensation45,400,000USD39,200,000USD41,200,000USD37,500,000USD40,200,000USD40,200,000USD42,100,000USD43,900,000USD
    Other Non Cash Items68,900,000USD77,900,000USD137,500,000USD45,700,000USD9,700,000USD22,000,000USD-3,354,800,000USD9,900,000USD
    Change To Account Receivables-117,900,000USD32,400,000USD13,200,000USD-24,900,000USD—-43,700,000USD47,300,000USD23,000,000USD
    Change To Inventory-1,600,000USD11,000,000USD-1,800,000USD41,600,000USD-100,000USD-100,000USD-41,200,000USD-94,200,000USD
    Change In Working Capital-501,500,000USD254,300,000USD83,500,000USD-141,700,000USD-150,700,000USD-150,700,000USD683,600,000USD-20,800,000USD
    Total Cash From Operating Activities43,800,000USD450,900,000USD573,700,000USD290,200,000USD280,400,000USD280,400,000USD351,800,000USD371,500,000USD
    Capital Expenditures-64,900,000USD-97,400,000USD-57,500,000USD-49,300,000USD-56,000,000USD-56,000,000USD-31,900,000USD-85,400,000USD
    Free Cash Flow-21,100,000USD353,500,000USD516,200,000USD240,900,000USD224,400,000USD224,400,000USD319,900,000USD286,100,000USD
    Investments69,000,000USD-117,700,000USD-427,800,000USD-172,100,000USD85,300,000USD-576,700,000USD2,701,700,000USD124,800,000USD
    Total Cashflows From Investing Activities-92,800,000USD-198,300,000USD-427,800,000USD-172,100,000USD85,300,000USD85,300,000USD2,701,700,000USD124,800,000USD
    Total Cash From Financing Activities-451,200,000USD-11,400,000USD-740,100,000USD52,700,000USD-258,000,000USD-258,000,000USD-976,700,000USD-96,600,000USD
    Sale Purchase Of Stock-521,800,000USD-40,599,999USD157,000,000USD-5,500,000USD-208,700,000USD-258,600,000USD-901,000,000USD-158,100,000USD
    Change In Cash-492,000,000USD244,700,000USD-595,200,000USD141,200,000USD90,000,000USD90,000,000USD2,035,400,000USD429,100,000USD
    Begin Period Cash Flow2,939,500,000USD2,694,800,000USD3,290,000,000USD3,148,800,000USD3,058,800,000USD3,058,800,000USD1,648,000,000USD1,228,200,000USD
    End Period Cash Flow2,447,500,000USD2,939,500,000USD2,694,800,000USD3,290,000,000USD3,148,800,000USD3,148,800,000USD3,683,400,000USD1,658,100,000USD
    Other Cashflows From Investing Activities-61,800,000USD-57,600,000USD-9,200,000USD-89,600,000USD141,300,000USD-54,000,000USD-77,700,000USD-23,500,000USD
    Other Cashflows From Financing Activities1,700,000USD-3,100,000USD-897,100,000USD1,000,000USD-49,300,000USD-50,000,000USD-75,700,000USD61,500,000USD
    Unclassified Operating Cash Flow9,400,000USD-54,400,000USD-18,000,000USD-20,900,000USD-13,400,000USD-24,100,000USD-123,000,000USD-66,100,000USD
    Unclassified Investing Cash Flow-35,100,000USD74,400,000USD66,700,000USD138,900,000USD-85,300,000USD772,000,000USD109,600,000USD108,900,000USD
    Unclassified Financing Cash Flow68,900,000USD32,299,999USD—57,200,000USD—50,600,000USD——
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income1,069,400,000USD4,169,700,000USD1,402,400,000USD1,521,900,000USD1,503,100,000USD823,400,000USD1,046,900,000USD722,200,000USD
    Depreciation156,600,000USD155,200,000USD144,900,000USD139,600,000USD134,800,000USD107,200,000USD89,300,000USD77,400,000USD
    Stock Based Compensation158,100,000USD162,300,000USD139,400,000USD126,800,000USD109,300,000USD92,600,000USD81,300,000USD71,000,000USD
    Other Non Cash Items174,100,000USD-3,362,200,000USD7,500,000USD105,800,000USD-119,000,000USD38,300,000USD154,100,000USD126,100,000USD
    Change To Account Receivables-23,000,000USD121,200,000USD-141,200,000USD-84,100,000USD-112,400,000USD283,900,000USD-94,800,000USD-13,000,000USD
    Change To Inventory50,700,000USD-256,100,000USD-289,000,000USD-213,400,000USD19,000,000USD-120,600,000USD-105,400,000USD-65,700,000USD
    Change In Working Capital154,600,000USD-259,300,000USD-526,300,000USD-421,400,000USD145,300,000USD42,200,000USD-204,300,000USD-42,600,000USD
    Total Cash From Operating Activities1,595,200,000USD542,300,000USD895,800,000USD1,218,200,000USD1,732,100,000USD1,054,300,000USD1,179,400,000USD926,800,000USD
    Capital Expenditures-260,200,000USD-252,400,000USD-266,300,000USD-264,800,000USD-329,800,000USD-407,300,000USD-278,400,000USD-241,700,000USD
    Free Cash Flow1,335,000,000USD289,900,000USD629,500,000USD953,400,000USD1,402,300,000USD647,000,000USD901,000,000USD685,100,000USD
    Investments-282,100,000USD2,312,900,000USD254,400,000USD252,300,000USD-1,335,200,000USD-101,700,000USD-158,200,000USD329,800,000USD
    Total Cashflows From Investing Activities-712,900,000USD2,312,900,000USD173,800,000USD252,300,000USD-1,722,500,000USD-531,100,000USD-595,800,000USD76,700,000USD
    Total Cash From Financing Activities-956,800,000USD-983,000,000USD-711,000,000USD-1,584,500,000USD-356,300,000USD-486,900,000USD-115,600,000USD-1,101,200,000USD
    Sale Purchase Of Stock-893,400,000USD-1,159,400,000USD-879,600,000USD-1,727,100,000USD-512,800,000USD-625,400,000USD-263,300,000USD-795,500,000USD
    Change In Cash-119,300,000USD1,910,800,000USD375,400,000USD-94,800,000USD-332,800,000USD15,800,000USD465,000,000USD-104,200,000USD
    Begin Period Cash Flow3,058,800,000USD1,148,000,000USD772,600,000USD867,400,000USD1,200,200,000USD1,184,400,000USD714,100,000USD818,300,000USD
    End Period Cash Flow2,939,500,000USD3,058,800,000USD1,148,000,000USD772,600,000USD867,400,000USD1,200,200,000USD1,179,100,000USD714,100,000USD
    Other Cashflows From Investing Activities-195,700,000USD3,745,300,000USD-75,000,000USD-63,100,000USD-359,300,000USD-446,400,000USD-183,200,000USD-4,800,000USD
    Other Cashflows From Financing Activities-237,500,000USD176,400,000USD168,900,000USD142,800,000USD158,300,000USD139,300,000USD35,000,000USD131,600,000USD
    Unclassified Operating Cash Flow-117,600,000USD-323,400,000USD-272,100,000USD-254,500,000USD-41,400,000USD-49,400,000USD12,100,000USD-27,300,000USD
    Unclassified Investing Cash Flow25,100,000USD-3,492,900,000USD260,700,000USD327,900,000USD301,800,000USD424,300,000USD24,000,000USD-6,600,000USD
    Unclassified Financing Cash Flow174,100,000USD—169,900,000USD146,400,000USD158,600,000USD140,500,000USD141,600,000USD688,000,000USD
    Net Borrowings——-300,000USD-200,000USD-1,800,000USD-800,000USD-10,000,000USD-437,300,000USD
    Dividends Paid——-169,900,000USD-146,400,000USD-158,600,000USD-140,500,000USD-18,900,000USD-688,000,000USD
    Change To Liabilities———-27,000,000USD257,200,000USD-137,400,000USD-20,300,000USD34,700,000USD
    Cash And Cash Equivalents Changes———-114,000,000USD-346,700,000USD36,300,000USD468,000,000USD-104,200,000USD
    Issuance Of Capital Stock——————160,500,000USD147,000,000USD
    Exchange Rate Changes———————-6,500,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-06-30ProductSurgical284,100,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductTranscatheter Aortic Valve Replacement1,258,300,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductTranscatheter Mitral And Tricuspid Therapies198,600,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31ProductSurgical276,200,000USD0001099800-26-000026
    Q1 2026Quarterly · 2026-03-31ProductTranscatheter Aortic Valve Replacement1,197,300,000USD0001099800-26-000026
    Q1 2026Quarterly · 2026-03-31ProductTranscatheter Mitral And Tricuspid Therapies175,100,000USD0001099800-26-000026
    Q4 2025Quarterly · 2025-12-31ProductSurgical Heart Valve Therapy253,600,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductTranscatheter Aortic Valve Replacement1,160,300,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductTranscatheter Mitral And Tricuspid Therapies155,700,000USDLegacy provider
    FY 2025Yearly · 2025-12-31ProductSurgical Heart Valve Therapy1,029,300,000USD0001099800-26-000009
    FY 2025Yearly · 2025-12-31ProductTranscatheter Aortic Valve Replacement4,487,700,000USD0001099800-26-000009
    FY 2025Yearly · 2025-12-31ProductTranscatheter Mitral And Tricuspid Therapies550,600,000USD0001099800-26-000009
    Q3 2025Quarterly · 2025-09-30ProductSurgical Heart Valve Therapy258,000,000USD0001099800-25-000062
    Q3 2025Quarterly · 2025-09-30ProductTranscatheter Aortic Valve Replacement1,149,900,000USD0001099800-25-000062
    Q3 2025Quarterly · 2025-09-30ProductTranscatheter Mitral And Tricuspid Therapies145,200,000USD0001099800-25-000062
    Q2 2025Quarterly · 2025-06-30ProductSurgical Heart Valve Therapy266,800,000USD0001099800-25-000048
    Q2 2025Quarterly · 2025-06-30ProductTranscatheter Aortic Valve Replacement1,130,900,000USD0001099800-25-000048
    Q2 2025Quarterly · 2025-06-30ProductTranscatheter Mitral And Tricuspid Therapies134,500,000USD0001099800-25-000048
    Q1 2025Quarterly · 2025-03-31ProductSurgical250,900,000USD0001099800-26-000026
    Q1 2025Quarterly · 2025-03-31ProductTranscatheter Aortic Valve Replacement1,046,600,000USD0001099800-26-000026
    Q1 2025Quarterly · 2025-03-31ProductTranscatheter Mitral And Tricuspid Therapies115,200,000USD0001099800-26-000026
    Q4 2024Quarterly · 2024-12-31ProductSurgical Heart Valve Therapy244,400,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductTranscatheter Aortic Valve Replacement1,036,300,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductTranscatheter Mitral And Tricuspid Therapies105,100,000USDLegacy provider
    FY 2024Yearly · 2024-12-31ProductSurgical Heart Valve Therapy981,300,000USD0001099800-26-000009
    FY 2024Yearly · 2024-12-31ProductTranscatheter Aortic Valve Replacement4,106,100,000USD0001099800-26-000009
    FY 2024Yearly · 2024-12-31ProductTranscatheter Mitral And Tricuspid Therapies352,100,000USD0001099800-26-000009
    Q3 2024Quarterly · 2024-09-30ProductSurgical Heart Valve Therapy240,000,000USD0001099800-25-000062
    Q3 2024Quarterly · 2024-09-30ProductTranscatheter Aortic Valve Replacement1,023,300,000USD0001099800-25-000062
    Q3 2024Quarterly · 2024-09-30ProductTranscatheter Mitral And Tricuspid Therapies91,100,000USD0001099800-25-000062
    FY 2023Yearly · 2023-12-31ProductSurgical Heart Valve Therapy932,600,000USD0001099800-26-000009
    FY 2023Yearly · 2023-12-31ProductTranscatheter Aortic Valve Replacement3,879,800,000USD0001099800-26-000009
    FY 2023Yearly · 2023-12-31ProductTranscatheter Mitral And Tricuspid Therapies197,600,000USD0001099800-26-000009
    FY 2022Yearly · 2022-12-31ProductSurgical Heart Valve Therapy829,700,000USD0001099800-25-000005
    FY 2022Yearly · 2022-12-31ProductTranscatheter Aortic Valve Replacement3,518,200,000USD0001099800-25-000005
    FY 2022Yearly · 2022-12-31ProductTranscatheter Mitral And Tricuspid Therapies116,100,000USD0001099800-25-000005
    FY 2021Yearly · 2021-12-31ProductCritical Care834,900,000USD0001099800-24-000004
    FY 2021Yearly · 2021-12-31ProductSurgical Heart Valve Therapy889,100,000USD0001099800-24-000004
    FY 2021Yearly · 2021-12-31ProductTranscatheter Aortic Valve Replacement3,422,500,000USD0001099800-24-000004
    FY 2021Yearly · 2021-12-31ProductTranscatheter Mitral And Tricuspid Therapies86,000,000USD0001099800-24-000004
    FY 2020Yearly · 2020-12-31ProductCritical Care725,400,000USD0001099800-23-000005
    FY 2020Yearly · 2020-12-31ProductSurgical Heart Valve Therapy761,800,000USD0001099800-23-000005
    FY 2020Yearly · 2020-12-31ProductTranscatheter Aortic Valve Replacement2,857,300,000USD0001099800-23-000005
    FY 2020Yearly · 2020-12-31ProductTranscatheter Mitral And Tricuspid Therapies41,800,000USD0001099800-23-000005
    FY 2019Yearly · 2019-12-31ProductCritical Care740,200,000USD0001099800-22-000005
    FY 2019Yearly · 2019-12-31ProductSurgical Heart Valve Therapy841,700,000USD0001099800-22-000005
    FY 2019Yearly · 2019-12-31ProductTranscatheter Aortic Valve Replacement2,737,900,000USD0001099800-22-000005
    FY 2019Yearly · 2019-12-31ProductTranscatheter Mitral And Tricuspid Therapies28,200,000USD0001099800-22-000005
    FY 2018Yearly · 2018-12-31ProductCritical Care674,500,000USD0001099800-21-000007
    FY 2018Yearly · 2018-12-31ProductSurgical Heart Valve Therapy761,600,000USD0001099800-21-000007
    FY 2018Yearly · 2018-12-31ProductTranscatheter Aortic Valve Replacement2,283,800,000USD0001099800-21-000007
    FY 2018Yearly · 2018-12-31ProductTranscatheter Mitral And Tricuspid Therapies2,900,000USD0001099800-21-000007
    Q3 2014Quarterly · 2014-09-30GeographyEurope176,900,000USD0001099800-15-000036
    Q3 2014Quarterly · 2014-09-30GeographyJapan66,800,000USD0001099800-15-000036
    Q3 2014Quarterly · 2014-09-30GeographyRest of World67,400,000USD0001099800-15-000036
    Q3 2014Quarterly · 2014-09-30GeographyUnited States296,300,000USD0001099800-15-000036
    Q2 2014Quarterly · 2014-06-30GeographyEurope193,800,000USD0001099800-15-000024
    Q2 2014Quarterly · 2014-06-30GeographyJapan66,700,000USD0001099800-15-000024
    Q2 2014Quarterly · 2014-06-30GeographyRest of World72,600,000USD0001099800-15-000024
    Q2 2014Quarterly · 2014-06-30GeographyUnited States242,000,000USD0001099800-15-000024
    FY 2012Yearly · 2012-12-31GeographyEurope577,000,000USD0001047469-15-000998
    FY 2012Yearly · 2012-12-31GeographyEurope559,700,000USD0001047469-15-000998
    FY 2012Yearly · 2012-12-31GeographyJapan293,400,000USD0001047469-15-000998
    FY 2012Yearly · 2012-12-31GeographyOther18,700,000USD0001047469-15-000998
    FY 2012Yearly · 2012-12-31GeographyRest of World233,700,000USD0001047469-15-000998
    FY 2012Yearly · 2012-12-31GeographyRest of World236,000,000USD0001047469-15-000998
    Q2 2012Quarterly · 2012-06-30GeographyEurope146,500,000USD0001047469-13-008139
    Q2 2012Quarterly · 2012-06-30GeographyJapan72,300,000USD0001047469-13-008139
    Q2 2012Quarterly · 2012-06-30GeographyRest of World56,200,000USD0001047469-13-008139
    Q2 2012Quarterly · 2012-06-30GeographyUnited States207,000,000USD0001047469-13-008139
    Q1 2012Quarterly · 2012-03-31GeographyEurope148,800,000USD0001047469-13-005581
    Q1 2012Quarterly · 2012-03-31GeographyJapan70,800,000USD0001047469-13-005581
    Q1 2012Quarterly · 2012-03-31GeographyRest of World53,000,000USD0001047469-13-005581
    Q1 2012Quarterly · 2012-03-31GeographyUnited States186,600,000USD0001047469-13-005581
    Q4 2011Quarterly · 2011-12-31GeographyEurope143,700,000USDLegacy provider
    Q4 2011Quarterly · 2011-12-31GeographyJapan76,800,000USDLegacy provider
    Q4 2011Quarterly · 2011-12-31GeographyRest of World55,000,000USDLegacy provider
    Q4 2011Quarterly · 2011-12-31GeographyUnited States154,700,000USDLegacy provider
    FY 2011Yearly · 2011-12-31GeographyEurope574,000,000USD0001047469-13-001954
    FY 2011Yearly · 2011-12-31GeographyJapan283,700,000USD0001047469-13-001954
    FY 2011Yearly · 2011-12-31GeographyRest of World215,300,000USD0001047469-13-001954
    FY 2011Yearly · 2011-12-31GeographyUnited States605,600,000USD0001047469-13-001954
    Q3 2011Quarterly · 2011-09-30GeographyEurope139,100,000USD0001047469-12-010132
    Q3 2011Quarterly · 2011-09-30GeographyJapan67,800,000USD0001047469-12-010132
    Q3 2011Quarterly · 2011-09-30GeographyRest of World55,300,000USD0001047469-12-010132
    Q3 2011Quarterly · 2011-09-30GeographyUnited States150,500,000USD0001047469-12-010132
    Q2 2011Quarterly · 2011-06-30GeographyEurope151,700,000USD0001047469-12-007817
    Q2 2011Quarterly · 2011-06-30GeographyJapan69,800,000USD0001047469-12-007817
    Q2 2011Quarterly · 2011-06-30GeographyRest of World58,400,000USD0001047469-12-007817
    Q2 2011Quarterly · 2011-06-30GeographyUnited States151,300,000USD0001047469-12-007817
    Q1 2011Quarterly · 2011-03-31GeographyEurope139,500,000USD0001047469-12-005578
    Q1 2011Quarterly · 2011-03-31GeographyJapan69,300,000USD0001047469-12-005578
    Q1 2011Quarterly · 2011-03-31GeographyRest of World46,600,000USD0001047469-12-005578
    Q1 2011Quarterly · 2011-03-31GeographyUnited States149,100,000USD0001047469-12-005578
    FY 2010Yearly · 2010-12-31GeographyEurope457,000,000USD0001047469-13-001954
    FY 2010Yearly · 2010-12-31GeographyJapan247,800,000USD0001047469-13-001954
    FY 2010Yearly · 2010-12-31GeographyRest of World174,600,000USD0001047469-13-001954
    FY 2010Yearly · 2010-12-31GeographyUnited States567,600,000USD0001047469-13-001954
    FY 2009Yearly · 2009-12-31GeographyEurope404,600,000USD0001047469-12-001617
    FY 2009Yearly · 2009-12-31GeographyJapan214,100,000USD0001047469-12-001617

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.